TETRAPHARM develops pharmaceutical drugs targeting the central nervous system and immune system to treat neurological and mental health disorders. Its proprietary drug‑delivery platform supports partners from early development through full‑scale production, using ZYNDIKATE®‑enabled CDMO solutions to create scalable, clinically robust products.
Funding
$9.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Neurological and mental health disorders often lack effective treatments due to challenges in delivering drugs to the central nervous system and immune system, especially for compounds with poor solubility or complex formulation requirements.
Solution
TETRAPHARM leverages its proprietary ZYNDIKATE® drug‑delivery platform to improve the bioavailability and uptake of CNS‑active compounds. The company offers end‑to‑end contract development and manufacturing (CDMO) services, guiding partners from early discovery through GMP‑scale production and commercialization. By providing a range of dosage formats—including sublingual sprays, nasal sprays, capsules, tablets, patches, and gels—ZYNDIKATE® enables scalable, clinically robust products for difficult‑to‑formulate molecules. TETRAPHARM’s scientific approach combines neuroscience expertise with delivery innovation to advance candidates for obesity, chronic pain, Alzheimer’s disease, and other mental health indications.
Target Audience
Primary customers are pharmaceutical companies and biotech firms developing CNS or immune‑targeted therapies that require advanced formulation and manufacturing support.
Features
- ZYNDIKATE® platform enhances uptake and bioavailability of poorly soluble CNS drugs
- Supports multiple administration routes (liquids, powders, sublingual spray, nasal spray, capsules, tablets, patches, gels)
- Full CDMO offering from early development to GMP‑scale manufacturing and market launch
- Tailored formulation solutions for complex molecules, improving product lifecycle and performance
- Integrated neuroscience expertise to align delivery technology with therapeutic targets